Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

被引：0
作者：
A J Gross
M Busse
J Leonard
H Schumacher
机构：
[1] Marien Krankenhaus,
[2] Boehringer Ingelheim Pharma GmbH & Co. KG,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2005年 / 8卷
关键词：
benign prostatic hyperplasia; lower urinary tract symptoms; phytotherapy; tamsulosin; postmarketing surveillance study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The aim of this observational prospective study was to evaluate the switch from phytotherapy to tamsulosin 0.4 mg once daily (o.d.) on efficacy, sexual function and tolerability in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) who have a poor response to at least 4 weeks of phytotherapy. The switch to tamsulosin 0.4 mg o.d. improves LUTS and related quality of life. Sexual function is also slightly improved. Tamsulosin is as well tolerated as phytotherapy and abnormal ejaculation appears to be no problem. Tamsulosin is perceived by both patients and urologists to be superior to preceding phytotherapy.
引用
收藏
页码：210 / 214
页数：4
相关论文
共 31 条
  • [1] Garraway WM(1991)High prevalence of benign prostatic hypertrophy in the community Lancet 338 469-471
  • [2] Collins GN(1993)The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 150 85-89
  • [3] Lee RJ(1999)Introduction and concluding remarks Eur Urol 36 1-6
  • [4] Chute CG(2004)State of the art on the efficacy and tolerability of Urology 64 1081-1088
  • [5] Chapple CR(2004)-AR antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) Eur Urol 3 60-1557
  • [6] Djavan B(1992)Comparison of the treatment regimes of new and existing LUTS/BPH patients in 6 European countries J Urol 148 1549-45
  • [7] Chapple C(1998)The American Urological Association symptom index for benign prostatic hyperplasia Eur Urol 34 37-506
  • [8] Milani S(2002)Tamsulosin, real life clinical experience in 19,365 patients Eur Urol 41 497-103
  • [9] Marberger M(1995)Comparison of a phytotherapeutic agent (Permixon) with an Arch Esp Urol 48 97-167
  • [10] Farmer R(1996)-blocker (tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year international randomised international study Eur Urol 30 77-900
1234